More forecasts: Atlanta 30 day forecast
AbbVie’s $744 Million Gut Punch Shakes 2026 Outlook For Chicago Investors
Apr 06, 2026
AbbVie said it will take a $744M pre‑tax charge for acquired IPR&D and milestone costs, trimming its 2026 adjusted EPS guidance to $13.96–$14.16. The hit reflects deal‑driven pipeline spending even as the company presses local investments.
Relativity Files Confidentially For IPO, Eyes $750M Raise
Mar 19, 2026
Chicago-based Relativity filed confidentially for an IPO; Bloomberg told the Chicago Business Journal the offering could raise about $750M and value the company near $4B. The company says it has supported legal teams for about 25 years.












